{"id":11332,"date":"2022-07-01T20:33:33","date_gmt":"2022-07-02T00:33:33","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/3-things-to-watch-for-in-clinical-trials-this-year\/"},"modified":"2022-07-14T16:04:46","modified_gmt":"2022-07-14T20:04:46","slug":"3-things-to-watch-for-in-clinical-trials-this-year","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/3-things-to-watch-for-in-clinical-trials-this-year","title":{"rendered":"3 Things to Watch for in Clinical Trials This Year"},"content":{"rendered":"<p style=\"text-align: center;\"><iframe loading=\"lazy\" allowfullscreen=\"\" frameborder=\"0\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/Zl_wazDnCVQ\" width=\"640\"><\/iframe><\/p>\n<p>On June 22, 2016, Jill O&rsquo;Donnell-Tormey, PhD, CEO and director of Scientific Affairs at the Cancer Research Institute, discussed the number and variety of immunotherapy clinical trials and what patients should look for.<\/p>\n<p>Cancer Research Institute&#39;s webinar series, &quot;Cancer Immunotherapy and You,&quot; are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&amp;A. This series is presented by Genentech and LabAnswer and its employees, with generous support from Abbvie, Celldex Therapeutics, NewLink Genetics, and Regeneron. For more information on this webinar, or to register for upcoming webinars, please visit <a href=\"https:\/\/www.cancerresearch.org\/webinars\">www.cancerresearch.org\/webinars<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr.&nbsp;Jill O&rsquo;Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials.<\/p>\n","protected":false},"featured_media":210,"template":"","events_categories":[198],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11332","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-webinars"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>3 Things to Watch for in Clinical Trials in 2016<\/title>\n<meta name=\"description\" content=\"Dr.\u00a0Jill O\u2019Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3 Things to Watch for in Clinical Trials in 2016\" \/>\n<meta property=\"og:description\" content=\"Dr.\u00a0Jill O\u2019Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T20:04:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/6fb053df-556b-45e4-9c5d-548f4b312394.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"3 Things to Watch for in Clinical Trials in 2016\" \/>\n<meta name=\"twitter:description\" content=\"Dr.\u00a0Jill O\u2019Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/6fb053df-556b-45e4-9c5d-548f4b312394.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year\",\"name\":\"3 Things to Watch for in Clinical Trials in 2016\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1ba4bbdb-ce4b-4e4b-936e-8649ca05b625.jpg\",\"datePublished\":\"2022-07-02T00:33:33+00:00\",\"dateModified\":\"2022-07-14T20:04:46+00:00\",\"description\":\"Dr.\u00a0Jill O\u2019Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1ba4bbdb-ce4b-4e4b-936e-8649ca05b625.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1ba4bbdb-ce4b-4e4b-936e-8649ca05b625.jpg\",\"width\":320,\"height\":208},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"3 Things to Watch for in Clinical Trials This Year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"3 Things to Watch for in Clinical Trials in 2016","description":"Dr.\u00a0Jill O\u2019Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year","og_locale":"es_ES","og_type":"article","og_title":"3 Things to Watch for in Clinical Trials in 2016","og_description":"Dr.\u00a0Jill O\u2019Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials","og_url":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T20:04:46+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/6fb053df-556b-45e4-9c5d-548f4b312394.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"3 Things to Watch for in Clinical Trials in 2016","twitter_description":"Dr.\u00a0Jill O\u2019Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/6fb053df-556b-45e4-9c5d-548f4b312394.jpg","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year","url":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year","name":"3 Things to Watch for in Clinical Trials in 2016","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1ba4bbdb-ce4b-4e4b-936e-8649ca05b625.jpg","datePublished":"2022-07-02T00:33:33+00:00","dateModified":"2022-07-14T20:04:46+00:00","description":"Dr.\u00a0Jill O\u2019Donnell-Tormey of the Cancer Research Institute discusses what patients should look for in immunotherapy clinical trials","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1ba4bbdb-ce4b-4e4b-936e-8649ca05b625.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1ba4bbdb-ce4b-4e4b-936e-8649ca05b625.jpg","width":320,"height":208},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/3-things-to-watch-for-in-clinical-trials-this-year#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"3 Things to Watch for in Clinical Trials This Year"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/210"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11332"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11332"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11332"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11332"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11332"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11332"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}